Rong Tang
机构:Jiangsu Provincial Center for Disease Control and Prevention · ORCID:0000-0002-1475-372X
发表论文 40 篇 · 总被引 2478 次 · h-index 15
代表论文
- Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial (2020 · The Lancet Infectious Diseases · 被引 1510)
- Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial (2022 · The Lancet Respiratory Medicine · 被引 172)
- Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 years: Report of the Randomized, Double-blind, and Placebo-controlled Phase 2 Clinical Trial (2020 · medRxiv · 被引 96)
- Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults: a multicentre, open-label phase 3 trial (2023 · The Lancet Infectious Diseases · 被引 54)
- Single-cell analysis of angiotensin-converting enzyme II expression in human kidneys and bladders reveals a potential route of 2019 novel coronavirus infection (2021 · Chinese Medical Journal · 被引 53)
- Real-world study of the effectiveness of BBIBP-CorV (Sinopharm) COVID-19 vaccine in the Kingdom of Morocco (2022 · BMC Public Health · 被引 52)